Category - Feature

Feature

Experity placing human connection at the center of AI-driven urgent care

Closely held Experity Health is shaping the future of healthcare by embedding AI into urgent care hubs across the U.S. to improve patient access, speed clinical visits, and elevate care quality.

November 11, 2025

Feature

Immuneering outpacing cancer with a novel approach to improving overall survival

Immuneering (NASDAQ: IMRX) is challenging conventional approaches of sustained inhibition in oncology by pioneering a novel class of therapies designed to outsmart cancer’s ability to adapt. With a proprietary platform...

October 28, 2025

Feature

In conversation with Dr. Tyler Evans, co-founder, CEO and CMO of Wellness Equity Alliance

Tyler B. Evans, MD, MS, MPH, is a leading voice in global health equity, infectious disease, and humanitarian medicine. As co-founder, CEO, and chief medical officer of Wellness Equity Alliance (WEA), Dr. Evans has...

October 21, 2025

Feature

Perimeter mitigating re-excisions with next-gen, AI-powered imaging breakthrough; potential FDA approval on the horizon

Perimeter Medical Imaging AI (TSX-V:PINK; OTCQX:PYNKF) is an early stage commercial growth company that is pioneering a breakthrough, ultra-high-res, AI-driven intraoperative margin visualization technology called B...

October 7, 2025

Feature

Cell One Partners guiding cell and gene therapy from breakthrough science to market impact

Consultancy Cell One Partners is helping innovators translate scientific ambition into viable commercial solutions as the cell and gene therapy industry pushes toward its next era of breakthroughs. Through deep domain...

September 30, 2025

Feature

Exousia Pro progressing scalable DNA-loaded exosomes toward the clinic

Exousia Pro (OTCPINK: MAJI) is developing a next-generation drug delivery platform using plant-based exosomes and a proprietary manufacturing process that could potentially address the biggest challenges in the...

September 16, 2025

Feature

Micoy engineering therapeutic decoys to block rogue autoantibodies

Closely held Micoy Therapeutics is advancing novel, first-in-class therapeutics to target harmful autoantibodies that induce immunodeficiency by inhibiting immune signaling molecules—type I interferons—which are...

September 9, 2025

Feature

Likarda seeks acquisition partner to accelerate cell therapy delivery breakthrough

Closely held Likarda is advancing a novel modality for delivering cellular therapies—a proprietary, customizable hydrogel delivery system engineered for controlled release, immune protection, and high cell viability.

September 2, 2025

Feature

Solu developing a powerful new therapeutic modality that unlocks cell surface targets

Closely held Solu Therapeutics is pairing heterobifunctional small molecules with monoclonal antibodies to develop therapeutic agents that eliminate disease-driving cells in cancer, immunology, and other therapeutic...

August 19, 2025

Feature

Ascentage reviving programmed cell death with novel approach to hematologic malignancies

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) is advancing its proprietary drug discovery platform of first- and best-in-class small molecule therapies to address unmet medical needs in cancers and other diseases.

August 12, 2025

Category - Feature

Subscribe